29.10.2023, 1395 Zeichen
UBM: In mid-May 2024, Gerald Beck will take over the position of Managing Director at Bundesimmobiliengesellschaft (BIG) and Austrian Real Estate (ARE) from Wolfgang Gleissner, who is retiring. Beck will therefore not extend his managing director contract at UBM Development Austria, which expires in the middle of the year. “UBM and ARE are linked by a strategic partnership in Munich and Vienna and it is always an honour when there is a friendly management change here,” commented Thomas G. Winkler, CEO of the listed parent company of UBM Austria. Beck will be succeeded on an interim basis by the new CTO and board member of UBM Development AG, Peter Schaller.
UBM: weekly performance:
KTM: In November 2022, KTM AG, a subsidiary of Pierer Mobility AG, by ways of a capital increase acquired a 25.1% stake in MV Agusta Motor S.p.A., based in Varese (Italy). As part of this cooperation, KTM AG took over the supply chain and purchasing for MV Agusta in October 2023. In addition, MV Agusta's product range is distributed through Pierer Mobility's worldwide sales network. The call option granted to KTM AG on the basis of the annual financial statements as of December 31, 2025 to acquire a majority stake in MV Agusta will be exercised in spring 2026.
Pierer Mobility: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (24/10/2023)
Börsepeople im Podcast S12/15: Anneliese Proissl
Aktien auf dem Radar:Palfinger, Immofinanz, Kapsch TrafficCom, Flughafen Wien, EuroTeleSites AG, Addiko Bank, Rosgix, Telekom Austria, RBI, SBO, Uniqa, ams-Osram, Oberbank AG Stamm, Agrana, Amag, CA Immo, Erste Group, EVN, FACC, OMV, Österreichische Post, VIG, Wienerberger, Warimpex, Henkel, Apple, Amgen, Deutsche Post, Vonovia SE, Beiersdorf, Münchener Rück.
Evotec
Evotec ist ein Wirkstoffforschungs- und -entwicklungsunternehmen, das in Forschungsallianzen und Entwicklungspartnerschaften mit Pharma- und Biotechnologieunternehmen, akademischen Einrichtungen, Patientenorganisationen und Risikokapitalgesellschaften Ansätze zur Entwicklung neuer pharmazeutischer Produkte vorantreibt.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten